Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study

Kozuch, P.S., Rocha-Lima, C.M., Dragovich, T., Hochster, H., O'Neil, B.H., Atiq, O.T., Pipas, J.M., Ryan, D.P., Lenz, H.; J Clin Oncol. 2008 May 10.

Haemodynamic effects of recombinant interleukin-2 administered by constant infusion

Groeger, J. S., Bajorin, D., Reichman, B., Kopec, I., Atiq, O., Pierri, M. K.; Eur J Cancer. 1991.

Therapy of upper gastrointestinal tract cancers.

Kelsen, D., Atiq, O. T.; Curr Probl Cancer. 1991 Sep 01.

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen, D., Atiq, O. T., Saltz, L., Niedzwiecki, D., Ginn, D., Chapman, D., Heelan, R., Lightdale, C., Vinciguerra, V., Brennan, M.; J Clin Oncol. 1992 Apr.

Cutaneous T-cell lymphoma presenting with diffuse lymphomatous infiltration of the peripheral nerves: response to combination chemotherapy.

Atiq, O. T., DeAngelis, L. M., Rosenblum, M., Portlock, C. S.; Am J Clin Oncol. 1992 Jun.

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.

Atiq, O. T., Kemeny, N., Niedzwiecki, D., Botet, J.; Cancer. 1992 Feb 15

Non-surgical treatment for liver metastases.

Kemeny, N. E., Atiq, O. T.; Baillieres Best Pract Res Clin Gastroenterol. 1999 Dec.

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

Atiq, O. T., Kelsen, D. P., Shiu, M. H., Saltz, L., Tong, W., Niedzwiecki, D., Trochanowski, B., Lin, S., Toomasi, F., Brennan, M.; J Clin Oncol. 1993 Mar.